Article
Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophrenia.
Psychiatric genetics - 1 Aug 2009
Butticaz Christophe, Werge Thomas, Beckmann Jacques S, Cuénod Michel, Do Kim Q, Rivolta Carlo
Abstract excerpt
BACKGROUND: Experimental evidences show that glutathione and its rate-limiting synthesizing enzyme, the glutamate-cysteine ligase (GCL), are involved in the pathogenesis of schizophrenia. Furthermore, genetic association has been previously reported between two single nucleotide polymorphisms lying in noncoding regions of glutamate cysteine ligase modifier (GCLM) gene, which specifies for the modifier subunit of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
